Michelle Van Handel

1.7k citations

30 papers · 1.3k indexed · 1 hit paper · h-index 12

Co-authors: Dawn K. Smith Behnam Badie Leying Zhang Jeremy A. Grey H. Irene Hall Linda A. Valleroy Joseph Prejean Linda J. Koenig
Topics: HIV, Drug Use, Sexual Risk (21 papers)HIV/AIDS Research and Interventions (17 papers)Sex work and related issues (6 papers)
Cited by: Infectious Diseases Epidemiology Virology
Journals: PLoS ONE NeuroImage PEDIATRICS
Partner nations: United States Kenya Finland

In The Last Decade

Michelle Van Handel

28 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition — United States, 2015

2015 299 citations Dawn K. Smith, Michelle Van Handel et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Countries citing papers authored by Michelle Van Handel

Since Specialization

Citations

This map shows the geographic impact of Michelle Van Handel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Van Handel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Van Handel more than expected).

Fields of papers citing papers by Michelle Van Handel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Van Handel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Van Handel. The network helps show where Michelle Van Handel may publish in the future.

Co-authorship network of co-authors of Michelle Van Handel

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Van Handel. A scholar is included among the top collaborators of Michelle Van Handel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Van Handel. Michelle Van Handel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs 2025 ·JAMA Health Forum ·Lin Zhu,Nathan W. Furukawa,W. Thompson,Marissa B Reitsma,Liisa M. Randall,Michelle Van Handel,Alice Asher,Eduardo Valverde,Benjamin P. Linas,Joshua A. Salomon	2
2	Testing trends and co-testing patterns for HIV, hepatitis C and sexually transmitted infections (STIs) in Emergency departments 2024 ·Preventive Medicine Reports ·(unknown),Michelle Van Handel,Amy L. Sandul,Angela B. Hutchinson,Clarisse A. Tsang,William S. Pearson,Kevin P. Delaney,Laura A. Cooley,Thomas L. Gift,Karen W. Hoover,W. Thompson	0
3	Cost-effectiveness of expanded hepatitis A vaccination among adults with diagnosed HIV, United States 2023 ·PLoS ONE ·(unknown),Michelle Van Handel,Yunfeng Tie,Lijing Ouyang,Noele P. Nelson,John Weiser	2
4	Methods for jurisdictional vulnerability assessment of opioid-related outcomes 2023 ·Preventive Medicine ·Shikhar Shrestha,(unknown),(unknown),(unknown),Michelle Van Handel,(unknown),Thomas J. Stopka	2
5	Estimated Uncovered Costs For HIV Preexposure Prophylaxis In The US, 2018 2023 ·Health Affairs ·Robert A. Bonacci,Michelle Van Handel,(unknown),Seidu Inusah,Dawn K. Smith	9
6	Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic 2021 ·American Journal of Preventive Medicine ·Harvey W. Kaufman,Lara Bull–Otterson,William A. Meyer,Xiaohua Huang,Mona Doshani,W. Thompson,(unknown),Mohammed A. Khan,Aaron M. Harris,Neil Gupta,Michelle Van Handel,Carolyn Wester,Jonathan Mermin,Noele P. Nelson	60
7	Characterizing opioid-involved overdose risk in local communities: An opioid overdose vulnerability assessment across Indiana, 2017 2021 ·Preventive Medicine Reports ·(unknown),Shikhar Shrestha,(unknown),Robert Gottlieb,(unknown),Michelle Van Handel,(unknown),Thomas J. Stopka	10
8	Counties with High COVID-19 Incidence and Relatively Large Racial and Ethnic Minority Populations — United States, April 1–December 22, 2020 2021 ·MMWR Morbidity and Mortality Weekly Report ·(unknown),Laura E. Adams,(unknown),Greta M. Massetti,(unknown),Ana Penman‐Aguilar,S. Jane Henley,Francis Annor,Michelle Van Handel,(unknown),Tonji Durant,Jonathan Fuld,Sean M. Griffing,(unknown),Leandris Liburd	23
9	Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 2020 ·Public Health Reports ·Mary E. Evans,Marissa K. Person,Brigg Reilley,Jessica Leston,(unknown),Jeffrey McCollum,Andria Apostolou,Michele K. Bohm,Michelle Van Handel,Danae Bixler,Andrew Mitsch,Dana L. Haberling,Sarah M. Hatcher,Thomas Weiser,(unknown),Eyasu H. Teshale,Paul J. Weidle,Philip J. Peters,Kate Buchacz	4
10	Factors Associated with State Variation in Mortality Among Persons Living with Diagnosed HIV Infection 2019 ·Journal of Community Health ·Amy Krueger,Michelle Van Handel,Patricia M. Dietz,(unknown),Anna Satcher Johnson,Pamela W. Klein,Stacy M. Cohen,(unknown),Laura W. Cheever,Philip Rhodes,David W. Purcell	3
11	Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015 2018 ·Annals of Epidemiology ·Dawn K. Smith,Michelle Van Handel,Jeremy A. Grey	189
12	Estimates of CDC-Funded and National HIV Diagnoses: A Comparison by Demographic and HIV-related Factors 2016 ·AIDS and Behavior ·Amy Krueger,Patricia M. Dietz,Michelle Van Handel,Lisa Belcher,Anna Satcher Johnson	8
13	Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs — United States 2016 ·MMWR Morbidity and Mortality Weekly Report ·Cyprian Wejnert,Kristen L. Hess,H. Irene Hall,Michelle Van Handel,(unknown),Paul Fulton,Qian An,Linda J. Koenig,Joseph Prejean,Linda A. Valleroy	84
14	Factors Associated with Time Since Last HIV Test Among Persons at High Risk for HIV Infection, National Survey of Family Growth, 2006–2010 2015 ·AIDS Patient Care and STDs ·Michelle Van Handel,Bridget H. Lyons,Emeka Oraka,Muazzam Nasrullah,Elizabeth DiNenno,Patricia M. Dietz	8
15	Centers for Disease Control and Prevention Funding for HIV Testing Associated With Higher State Percentage of Persons Tested 2015 ·Journal of Public Health Management and Practice ·Samah Hayek,Patricia M. Dietz,Michelle Van Handel,Jun Zhang,Ram K. Shrestha,Ya-Lin A. Huang,Choi K. Wan,Jonathan Mermin	5
16	Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition — United States, 2015breakdown → 2015 ·MMWR Morbidity and Mortality Weekly Report ·Dawn K. Smith,Michelle Van Handel,Richard J. Wolitski,Jo Ellen Stryker,H. Irene Hall,Joseph Prejean,Linda J. Koenig,Linda A. Valleroy	299
17	HIV Testing among Outpatients with Medicaid and Commercial Insurance 2015 ·PLoS ONE ·Patricia M. Dietz,Michelle Van Handel,Huisheng Wang,Philip J. Peters,Jun Zhang,Abigail H. Viall,Bernard M. Branson	8
18	Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice 2009 ·Glia ·Leying Zhang,Darya Alizadeh,Michelle Van Handel,Marcin Kortylewski,Hua Yu,Behnam Badie	155
19	Regulation of IL-10 expression by upstream stimulating factor (USF-1) in glioma-associated microglia 2007 ·Journal of Neuroimmunology ·Lu Zhang,Michelle Van Handel,(unknown),(unknown),(unknown),(unknown),Behnam Badie	33
20	Impaired capacity for upregulation of MHC class II in tumor‐associated microglia 2005 ·Glia ·Jill Schartner,(unknown),Michelle Van Handel,Leying Zhang,Nivedita Nadkarni,Behnam Badie	109

About Michelle Van Handel

Michelle Van Handel is a scholar working on Infectious Diseases, Epidemiology and Hepatology, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (21 papers), HIV/AIDS Research and Interventions (17 papers) and Sex work and related issues (6 papers). The work is most often cited by research in Infectious Diseases (700 citations), Epidemiology (682 citations) and Virology (73 citations). Michelle Van Handel has collaborated with scholars based in United States, Kenya and Finland. Frequent co-authors include Dawn K. Smith, Behnam Badie, Leying Zhang, Jeremy A. Grey, H. Irene Hall, Linda A. Valleroy, Joseph Prejean, Linda J. Koenig, Jo Ellen Stryker and Richard J. Wolitski. Their work appears in journals such as PLoS ONE, NeuroImage and PEDIATRICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact